Ryzodeg® FlexTouch® (RYZODEG® FlexTouch®)

Kamfanin masana'antar ba ta tsayawa tsayawa ba - kowace shekara tana ba da magunguna masu haɓaka da ingantattun magunguna.

Insulin ba banda bane - akwai sabbin bambance-bambance na kwayar halittar, wanda aka tsara don sauƙaƙa rayuwa ga marasa lafiya da ke fama da ciwon sukari, wanda kowace shekara ke ƙaruwa sosai.

Daya daga cikin abubuwan ci gaba na zamani shine insulin Raizodeg daga kamfanin Novo Nordisk (Denmark).

Halaye da halayyar insulin

Ryzodeg insulin aiki ne mai dadewa. Ruwan mara haske ne mara launi.

An samo shi ta injiniyan kwayoyin ta hanyar maye gurbin kwayar halittar DNA ta ɗan adam ta amfani da nau'in yisti na Saccharomyces cerevisiae.

A cikin tsarinta an haɗa insulins biyu: Degludec - mai aiki da dogon-wuri da kuma Aspart - a takaice, a cikin rabo na 70/30 a cikin raka'a 100.

A cikin raka'a 1 na insulin Ryzodeg ya ƙunshi 0.0256 mg Degludek da 0.0105 mg Aspart. Penaya daga cikin alkalami guda ɗaya (Raizodeg Flex Touch) ya ƙunshi 3 ml na bayani, bi da bi raka'a 300.

Haɗakarwa ta musamman ta masu adawa da insulin guda biyu ta ba da kyakkyawan sakamako na hypoglycemic, mai sauri bayan gudanarwa kuma ya daɗe na sa'o'i 24.

Hanyar aiwatarwa shine hadin gwiwar magungunan da aka gudanar tare da masu karɓar insulin na haƙuri. Sabili da haka, an gano magani kuma an inganta sakamako na asali na hypoglycemic.

Basal Degludec ya samar da microcameras - takamammen depot a cikin yankin subcutaneous. Daga can, insulin na dogon lokaci a hankali yana rarrabewa kuma baya hana sakamako kuma baya tsoma baki tare da ɗaukar gajeren ƙwayar insulin.

Insulin Rysodeg, a layi daya tare da gaskiyar cewa yana inganta rushewar glucose a cikin jini, yana toshe hanyoyin da ke gudana daga hanta.

Umarnin don amfani

Magungunan Ryzodeg an gabatar dashi ne a cikin kitse mai kitse. Ba za a iya allurar dashi ko dai cikin ciki ko intramuscularly.

Yawanci ana ba da shawarar yin allura a ciki, cinya, ƙasa da sau a kafada. Wajibi ne a canza wurin allurar gwargwadon ka'idodin ƙa'idodin gabatarwar algorithm.

Idan allura ta gudana ta hanyar Ryzodeg Flex Touch (sirinji alkalami), to lallai ne ku bi ka'idodin:

1. Tabbatar cewa dukkan bangarorin suna cikin akwati wanda ke dauke da 3 kwatin 3 ml ya ƙunshi 300 IU / ml na miyagun ƙwayoyi.
2. Bincika allura mai diski NovoFayn ko NovoTvist (tsayin 8 mm).
3. Bayan cire hula, duba mafita. Ya kamata a bayyana gaskiya.
4. Saita sigar da ake so akan lakabi ta hanyar mai zaɓi.
5. Danna kan "farawa", riƙe har digo na bayani ya bayyana a saman allura.
6. Bayan allurar, yakamata ya zama 0. Cire allurar bayan dakika 10.

Ana amfani da zane-zane don amfani da matatun “alkalama”. Mafi karɓa shine Ryzodeg Penfill.

Rysodeg Flex Touch - alkalami na sake amfani dashi. Tabbatar da ɗaukar sabon allura don kowane allura.

Flexpen wani sirinji na alkalami wanda za'a iya dashi dashi tare da penfill (kabad).

An wajabta Risodeg ga marasa lafiya masu fama da nau'in 1 da nau'in ciwon sukari na 2. An wajabta shi sau 1 kowace rana kafin babban abincin. A lokaci guda, ana yin insulin gajerun abubuwa kafin kowane abinci.

Syringe alkalami allura bidiyo koyawa:

Ana yin lissafin kashi tare da kulawa da kulawa akai-akai na glucose a cikin jinin mai haƙuri. An ƙididdige shi akayi daban-daban ga kowane mara lafiya ta ƙwararren likitancin endocrinologist.

Bayan gudanarwa, ana shan insulin cikin sauri - daga mintina 15 zuwa awa 1.

Magungunan ba su da maganin cutar cututtukan koda da hanta.

Ba da shawarar yin amfani da:

• yara ‘yan kasa da shekara 18
• yayin daukar ciki
• yayin shayarwa
• tare da kara yawan hankalin mutum.

Babban analogues na Ryzodeg sune sauran insulins da suka dade suna aiwatarwa. Lokacin maye gurbin Ryzodeg tare da waɗannan kwayoyi, a mafi yawan lokuta ba su ma canza sashi ba.

Daga cikin waɗannan, mafi mashahuri:

Kuna iya kwatanta su bisa teburin:

Wajibi ne a yi la’akari da sharhi game da gudanarwar Tujeo: yana da kyau kuma a hankali a bincika ƙimar aikin alkalami na SoloStar, tun da ɓarna na iya haifar da zubar da rashin gaskiya a cikin kashi. Hakanan, saurin saurin kuka shine ya zama dalilin bayyanar ra'ayoyi da dama mara kyau akan majalisun.

Farashin magani

An ba da shawarar cewa yawancin insulin da ke gudanarwa a cikin jiyya na nau'in 1 mellitus na sukari shine Ryzodegum.

Nau'in masu ciwon suga guda 2 tare da kashi na Ryzodeg insulin yakamata a basu kowace rana.

Akwai sake dubawa masu inganci da yawa game da tasiri na miyagun ƙwayoyi - ya shahara sosai, kodayake sayen magani a cikin kantin magani ba shi da sauƙi.

Farashin zai dogara da nau'in sakin.

Farashin Ryzodeg Penfill - katun gilashin gilashin 300 na 3 ml kowannensu zai tashi daga 6594, 8150 zuwa 9050 har ma 13000 rubles.

Raizodeg FlexTouch - alkalami mai sihiri 100 IU / ml a cikin 3 ml, A'a 5 a cikin kunshin, zaku iya siye daga 6970 zuwa 8737 rubles.

Wajibi ne a la'akari da gaskiyar cewa a yankuna daban-daban da kuma kantin magunguna masu zaman kansu farashin zai bambanta.

Tsarin ilimin rayuwa (ICD-10)

Abun ciki da kaddarorin

Ryzodeg shine sabon ƙarni na insulin basal wanda za'a iya amfani dashi cikin nasara don magance nau'in 1 da nau'in ciwon sukari na 2. Rashin daidaituwa na Rysodegum ya ta'allaka ne akan cewa a lokaci guda ya kunshi insulin-gajere-insulin aiki da insulin na super-tsawan aiki na degludec.

Dukkanin insulins da aka yi amfani dasu don ƙirƙirar shirye-shiryen Ryzodeg sune analogues na insulin mutum. Ana samun su ta hanyar ilimin halittar halittar DNA ta hanyar amfani da yisti na sel na sel na Saccharomyces cerevisiae.

Saboda wannan, suna ɗaure sauƙin zuwa mai karɓar insulin nasu na mutum kuma, yayin ma'amala da shi, yana haɓaka ingantaccen ƙwayar glucose. Saboda haka, Ryzodegum yana aiki cikakke azaman insulin insulin.

Ryzodeg yana da sakamako mai ninki biyu: a gefe guda, yana taimakawa tsokoki na ciki don samun mafi kyawun ƙwayar sukari daga jini, kuma a ɗayan, yana rage mahimmancin samar da glycogen ta ƙwayoyin hanta. Wadannan kaddarorin suna sanya Ryzodeg daya daga cikin ingantaccen insulin basal mai aiki.

Insulin degludec, wanda shine ɗayan kayan haɗin Ryzodeg, yana da ƙarin aiki mai tsayi. Bayan gabatarwa cikin ƙwayar subcutaneous, yana sannu a hankali kuma ya ci gaba da shiga cikin jini, wanda ya ba mai haƙuri damar hana haɓakar sukari na jini sama da matakin al'ada.

Saboda haka, Ryzodeg yana da tasirin hypoglycemic sakamako, duk da haɗuwar degludec da kewayawa. Wadannan abubuwan biyu suna haifar da sakamako na insulin a cikin wannan ƙwayar cuta suna haifar da ingantaccen haɗin haɗin gwiwa wanda tsawon insulin baya hana ɗaukar gajere.

An fara aiki da kai tsaye bayan allurar Ryzodegum. Yana cikin sauri yana shiga cikin jinin mai haƙuri kuma yana taimakawa sosai don rage matakan sukarin jini.

Furtherarin gaba, degludec yana fara tasiri a jikin mai haƙuri, wanda ke ɗaukar hankali a hankali kuma yana haɗuwa da cikakkiyar haƙuri na buƙatar basal insulin na tsawon awanni 24.

Fom ɗin saki

Ana samun magungunan a cikin nau'i mai tsabta don sarrafawar intradermal. Ana sanya mafita a cikin gilashin gilashi, wanda shine ɓangaren firinji na Flextach. Tare da taimakonsa, mutum zai iya saita kashi daga raka'a 1 zuwa 80. Specializedaya daga cikin alkalami na musamman ya ƙunshi 3 ml (1 ml / 100 PIECES) na bayani. A cikin kunshin ɗayan akwai sirinji 5 cike.

Kula! Haramun ne a cika matattarar “Rysodeg”. Kafin amfani da maganin, dole ne a hankali bincika ƙa'idodi don aiki tare da sirinji na musamman.

Magunguna da magunguna

Magungunan magani na Ryzodeg cikakkun analogues ne na insulin halittar jini. Bayan gudanarwa, insulin degludec yana samarda abin da ake kira masu suna multihexamers, wanda ke ba da izinin samar da shi sannu a hankali na dogon lokaci. Insulin kamar yadda ya fara aiki a cikin mintuna 10 zuwa 20, don haka ya kawar da bukatun jikin mutum na insulin. Abubuwan da ke cikin magungunan sun ɗaure wa masu karɓar insulin na ɗan adam, bayan haka suna ƙaruwa da yawan amfani da glucose da rage ƙimar samar da glucose ta hanta.

Bayan gudanarwa, masu samar da abubuwa da yawa daga insulin insulin su fara farawa. Sakin hankali na kwantar da magungunan a cikin jini ya samo asali ne sakamakon sakin kwastomomin degludec. Tsarin wucewa baya hana kewayawa cikin jini cikin hanzari bayan allura. Don haka, yana yiwuwa a cimma nasarar hada shi.

Rabin rayuwar abubuwan sinadaran masu aiki kamar sa'o'i 25 ne. Darajar ta dogara ne da yawan narkewar degludec. A sashi na miyagun ƙwayoyi ba ya shafar lokaci.

Manuniya da contraindications

Abinda kawai ke nuna amfanin Ryzodeg shine ciwon sukari na nau'in farko ko na biyu. Daga cikin contraindications don amfani, akwai:

• rashin haƙuri zuwa ɗayan abubuwan da ke cikin miyagun ƙwayoyi,
• ciki da lactation,
• yara ‘yan kasa da shekara 18.

Rashin amfani da miyagun ƙwayoyi a lokacin ƙuruciya ko lokacin daukar ciki da lactation saboda gaskiyar cewa babu gwajin asibiti a cikin wannan rukunin mutanen. Koyaya, nazarin dabbobi sun nuna cewa degludec na iya kasancewa a cikin madarar nono. Kafin amfani da Ryzodeg, ya kamata a gudanar da jarrabawa don abubuwan da suka yiwu.

Side effects

Amfani da wannan magani mara kyau na iya haifar da sakamako masu illa. Daga cikin abubuwanda suka saba faruwa sune:

• hawan jini,
• fata halayen a wurin allura,
• lipodystrophy.

A cikin mafi yawan lokuta mafi wuya, mutum na iya fuskantar rashin lafiyar jiki da halayen rashin lafiyan mutum.

Hypoglycemia yana daya daga cikin cututtukan da suka zama ruwan dare lokacin amfani da shi. Yana wakiltar raguwa a cikin tattarawar glucose a cikin jini. Wannan sakamako na gefen yana faruwa saboda kashi da aka zaɓi da kyau. Halin yana nunawa ta tsananin farin ciki, yanayin illa, fatar fata, hangen nesa da kuma gumi mai sanyi. Hematomas, kumburi, itching da haushi na iya faruwa a wurin allurar. A matsayinka na mai mulkin, wadannan bayyanar za su shuɗe da kansu kuma ba su haifar da wata barazana.

Mahimmanci! Idan sakamako masu illa sun faru, mutum ya nemi taimako daga likita. Kowane haƙuri tare da masu ciwon sukari ya kamata ya san yadda za a nuna hali a lokacin da hypoglycemia mai sauƙi ya faru.

Sashi da yawan abin sama da ya kamata

Sashi aka zaɓi akayi daban-daban. A matsayinka na mai mulkin, ana yin allura sau 1-2 a rana kafin manyan abinci. A lokacin jiyya, daidaitawa na iya faruwa bisa ga sukarin jini. Dangane da umarnin hukuma, an bambanta shawarwarin da ke gaba:

• tare da nau'in ciwon sukari na 2, maganin farko na yau da kullun shine raka'a 10,
• tare da nau'in ciwon sukari na 1, tsarin kulawa ta "Ryzodeg" ya dogara da amfani da wasu magungunan insulin,
• lokacin allura yana faruwa ne ta hanyar abincin farko kuma yana iya bambanta.

Don kowace gudanarwa na miyagun ƙwayoyi, dole ne a yi amfani da sabon allura. Ba a haɗa su cikin kunshin ba, saboda haka dole ne a saya su daban. Lokaci na farko da amfani da insulin "Raizodeg" anfi dacewa da za'ayi a ƙarƙashin kulawar likita ko kuma likitan mata. Kuna iya nemo yadda ake yin allura a cikin bidiyon a mahadar:

Tare da yawan abin sama da ya wuce, hypoglycemia na faruwa. Yana da kyau a lura cewa a cikin kowane mutum overdose bayyananne bayyana daga allurai daban-daban. Idan sukari na jini ya ragu kaɗan, to za a iya kawar da matsalar da kanta - kuna buƙatar amfani da samfurin da ke ɗauke da sukari. A lokuta masu wahala, ana buƙatar asibiti.

Haɗa kai

Magungunan yana ma'amala da nau'ikan magunguna masu zuwa:

• maharan hypoglycemic
• ACE masu hanawa
• glucocorticosteroids,
• Samfuran Testosterone
• MAO masu hanawa
• cututtukan mahaifa.

Suna iya ƙaruwa ko rage buƙatar insulin. Tare da yin amfani da lokaci ɗaya tare da daidaitawar kashi "Ryzodeg" za'a buƙaci mafi girma ko ƙasa.

Tare tare da wannan magani, ana iya amfani da wasu hanyoyi don dakatar da ciwon sukari. Ya kamata likitan ilimin endocrinologist ya kirkiro tsarin kulawa tare da yin la'akari da hulɗa da kowane magani.

Yana da mahimmanci a lura cewa barasa na iya shafar tasirin magungunan magunguna. Ya kamata a kula da amfani da shi idan cutar siga ta kasance. Dole ne likita ya yi la'akari da irin magungunan da mutum yake amfani da shi don zaɓar madaidaicin sashi.

Babu matsala ya kamata ku haɗu da maganin tare da sauran magunguna don ƙarin gudanarwa. Idan likita zai tsara tsarin magani don kawar da cututtukan ɓangare na uku, kuna buƙatar sanar da shi cewa ana aiwatar da amfani da Raizodeg.

Daga cikin cikakkun analogues na miyagun ƙwayoyi, Penzoill kawai, wanda Novo Nordinsk ya bayar, an rarrabe.

Daga cikin cikakkiyar irin wannan hanyar bambanta:

Samun samfurin gaba ɗaya mai kama da juna a Rasha wanda zai yi amfani da haɗakar abubuwa insulin mai saurin ɗaukar nauyi da wahala.

Ra'ayoyin mutanen da suka yi amfani da wannan haɗin maganin don maganin ciwon sukari:

Na sauya zuwa Ryzodeg kwanan nan. Daga cikin fa'idodin wannan insulin ina so in haskaka da sakamako mai tsawo da sakamako mai sauri. Sirinji ya dace don amfani. Girman kashi yana bayyane a bayyane, duk da cewa ba ni da kyakkyawan gani sosai.

Tatyana, shekara 54

Ina ganin Ryzodeg daya daga cikin nau'ikan insulin da aka fi so. Iyakar abin da ya jawo shine farashin. Na jima ina amfani da ita. Ba a taɓa samun sakamako masu illa ba.

Tare da taimakon Ryzodeg, na sami damar dakatar da ciwon sukari na 2. Yin amfani da alƙalar syringe don yin allura ta yau da kullun ba wuya. A halin yanzu ina amfani da miyagun ƙwayoyi kusan a cikin awanni 24.

Farashin magani ya bambanta daga 6900 zuwa 8500 rubles. Zai fi dacewa sayi magani kawai a cikin magunguna masu lasisi. Bayan sayan, kuna buƙatar bincika samfurin a hankali. Idan ruwan da ke cikin katun bai cika kwatancen a cikin umarnin ba, to, an hana maganin.

Kammalawa

"Rysodeg" Flextach magani ne mai ƙoshin lafiya wanda za'a iya amfani dashi don ciwon sukari a zaman wani ɓangaren hadaddun ko monotherapy. Abu ne mai sauqi ka gudanar da maganin godiya ga kwararrun sirinji. Don aminci, mutum ya kamata ya yi amfani da sababbin allura tare da kowane allura. Hakanan wajibi ne don ziyartar likita a kai a kai don lura da tasirin magani. Idan komai yana tsari, to ana amfani da insulin ne a allurai.

Informationarin bayani game da lokacin da likitoci suka tsara magunguna na insulin a cikin bidiyon:

Pharmacokinetics

Baƙon Bayan allurar sc, da samuwar insulin mahalli mai narkewa mai narkewa mai narkewa mai yawa, wanda ke haifar da insulin kwayar halitta a cikin kashin da ke gab da lalacewa, kuma kada ku tsoma baki tare da saurin sakin insulin masu bi da bi a cikin jijiyoyin jijiyoyin jiki.

Heaƙƙarfan ƙwayoyi suna rarrabewa, da sakin ƙwararrun insulin degludec, wanda ke haifar da jinkirin ci gaba da ƙwayar magunguna zuwa jini. C_ss wani bangare ne na babban aikin (insulin degludec) a cikin jini yana gudana ne kwanaki 2-3 bayan gudanar da shirye-shiryen Ryzodeg ®.

Sanannun alamun alamun saurin ƙwayar insulin aspart an adana su a cikin ƙwayar Risedeg ®. Bayanan likitancin insulin na kanfanin insulin yana fitowa a cikin mintuna 14 bayan allura, C_max lura bayan minti 72

Rarraba. Haɗin insulin degludec insulin na albumin yayi daidai da ƙarfin ɗaukar ƙwayar plasma> kashi 99% cikin jini na mutum. Don insulin aspart, ƙwayar ƙwayar plasma yana da ƙananan ƙarfi (T_1/2 Ryzodeg ® bayan allura s / c an ƙaddara shi da ƙimar ɗarin ƙwaƙwalwa daga ƙwayar katako. T_1/2 Insulin Degludec yana kamar awanni 25 kuma yana da magani mai zaman kansa.

Rashin layi. Sakamakon duka na Ryzodeg ® ya zama daidai da kashi na abubuwan basal (insulin degludec) da kuma nau'in prandial (insulin aspart) a cikin marasa lafiya da ke da nau'in 1 da 2 na ciwon sukari.

Groupsungiyoyin haƙuri na musamman

PaulBabu bambance-bambance da aka samo a cikin kundin magungunan Ryzodeg ® dangane da jinsi na marasa lafiya.

Tsofaffi marasa lafiya, marasa lafiya na kabilu daban-daban, marasa lafiya da ke fama da rauni ko aikin hepatic. Ba a sami bambance-bambance mai mahimmanci na asibiti ba a cikin magungunan magunguna na Ryzodeg ® tsakanin tsofaffi da matasa marasa lafiya, marasa lafiya na kabilu daban-daban, marasa lafiya da ke fama da rauni na aiki da aikin hepatic, da kuma marasa lafiya masu lafiya.

Yara da matasa. Abubuwan da ke cikin pharmacokinetic na miyagun ƙwayoyi Risedeg ® a cikin wani binciken a cikin yara (shekaru 6-1 da haihuwa) da kuma matasa (12-18 years old) tare da nau'in ciwon sukari na 1 na sukari wanda yake daidai da waɗanda ke cikin tsofaffi marasa lafiya akan asalin allurar guda. Jimlar taro da C_max insulin aspart yana da girma a cikin yara fiye da manya kuma iri ɗaya ne a cikin samari da tsofaffi. Abubuwan da ke cikin pharmacookinetic na insulin degludec a cikin yara da matasa tare da nau'in ciwon sukari na 1 suna kama da waɗanda ke cikin marasa lafiyar manya.

A kan banbancin allurar guda na kwatancen insulin degludec a cikin marasa lafiya da ke dauke da nau'in 1 na ciwon sukari na mellitus, an nuna cewa jimlar maganin maganin ƙwaƙwalwa a cikin yara da matasa sun yi girma fiye da na masu haƙuri.

Karatun Tsaro na Lafiya

Bayanai na asibiti wanda ya danganci karatun lafiya, game da cututtukan maimaikon jiki, yawan cutarwa, da yawan cututtukan cututtukan dabbobi, illa mai guba kan aikin haifuwa bai bayyana wani hatsari ga dan adam ba. Rashin aiki na rayuwa da aikin mitogenic na insulin degludec yayi daidai da na insulin na mutum.

Contraindications

increasedara yawan ji da kai ga abubuwan da ke aiki ko wasu abubuwan taimako na miyagun ƙwayoyi,

lokacin shayarwa,

yara 'yan kasa da shekaru 18 (babu wani ƙwarewar asibiti tare da amfani da miyagun ƙwayoyi a cikin yara, mata yayin daukar ciki da shayarwa).

Haihuwa da lactation

Yin amfani da miyagun ƙwayoyi Risedeg ® FlexTouch ® yayin daukar ciki yana contraindicated, saboda babu ƙwarewar asibiti tare da amfanin sa yayin daukar ciki. Nazarin aikin dabbobi na dabbobi bai bayyana bambance-bambance tsakanin insulin degludec da insulin na mutum dangane da haihuwa da teratogenicity.

Amfani da miyagun ƙwayoyi Ryzodeg ® FlexTouch ® yayin shayarwa yana da sabani, saboda babu gogewar asibiti tare da matan masu shayarwa.

Nazarin dabbobi sun nuna cewa a cikin beraye, insulin degludec yana kwance a cikin madarar nono, kuma yawan ƙwayar magani a cikin madara nono ya ƙasa da na jini. Ba'a sani ba ko insulin degludec an keɓance shi cikin madara mata.

Haihuwa. Nazarin dabbobi ba su sami sakamako masu illa na insulin degludec ba akan haihuwa.

Sashi da gudanarwa

S / c 1 ko sau 2 a rana kafin manyan abinci. Idan ya cancanta, marasa lafiya suna da damar su canza lokacin sarrafa magani, amma ya kamata a ɗaure shi da babban abincin.

Ryzodeg ® FlexTouch a haɗuwa ne na insulin analogues - insulin basal mai aiki da lokaci (insulin ƙasa insulin) da insulin aiki mai saurin motsa jiki (insulin aspart). A cikin marasa lafiya waɗanda ke da nau'in ciwon sukari na 2 na sukari, ana iya amfani da Ryzodeg ® FlexTouch either azaman monotherapy, ko a hade tare da PHGP ko insalin ƙwaƙwalwar ƙwayar cuta. An tsara masu haƙuri waɗanda ke da nau'in 1 na sukari mellitus na Risodeg ® FlexTouch ® a hade tare da insulin gajere / matsanancin motsa jiki na insulin kafin sauran abinci.

An ƙaddara adadin Ryzodeg ® FlexTouch ® akayi daban-daban gwargwadon bukatun masu haƙuri. Don inganta sarrafa glycemic, ana bada shawara don daidaita sashi na miyagun ƙwayoyi dangane da ƙimar glucose na jini.

Kamar yadda yake tare da kowane shiri na insulin, ana iya buƙatar daidaita sashi idan aikin mai haƙuri ya ƙaru, abincin da ya saba ci, ko kuma yanayin rashin lafiya.

Maganin farko na Ryzodeg ® FlexTouch ®

Marasa lafiya tare da nau'in ciwon sukari na 2. Yankin da aka bada shawarar farko na Ryzodeg ® FlexTouch ® shine raka'a 10 tare da zaɓin ɗimbin maganin.

Marasa lafiya tare da nau'in ciwon sukari na 1. Shawarar fara amfani da Ryzodeg ® FlexTouch ® 60-70% ne na yawan insulin yau da kullun. Magungunan Ryzodeg ® FlexTouch ® an wajabta shi sau ɗaya a rana yayin babban abincin yayin haɗaka tare da insulin cikin sauri / gajere da ke gudana kafin sauran abinci, biye da zaɓi na adadin maganin.

Canja wuri daga sauran shirye-shiryen insulin

Kulawa da hankali game da tattarawar glucose na jini yayin canja wuri kuma a farkon makonni na sabon magani ana bada shawara. Ana iya buƙatar gyaran concomitant therapy hypoglycemic therapy (kashi da lokacin gudanar da gajeren insulin shirye-shiryen insulin ultrashort ko kuma adadin PHGP).

Marasa lafiya tare da nau'in ciwon sukari na 2. Lokacin canja wurin marasa lafiya da ke karbar bashin insulin basal ko bipisic insulin therapy sau ɗaya a rana, yakamata a kirga kashi na Ryzodeg ® FlexTouch on akan ƙayyadaddun kashi-kashi daga jimlar insulin na yau da kullun da mai haƙuri ya karɓa kafin canja wurin zuwa sabon nau'in insulin. Lokacin canja wurin marasa lafiya waɗanda suke kan aikin insulin na basal ko biphasic insulin guda ɗaya, yakamata a ƙididdige yawan Ryzodeg ® FlexTouch ® akan tsarin-da-naúrar, tare da canja wurin zuwa sau biyu na Ryzodeg ® FlexTouch ® a cikin yawan jimlar insulin na yau da kullun, wanda mai haƙuri ya karɓa kafin canja wuri zuwa sabon nau'in insulin. Lokacin canja wurin marasa lafiya waɗanda ke kan dalilin ƙirar bolus na tsarin insulin, kashi Ryzodeg ® ya kamata a lissafta gwargwadon buƙatun mutum na mai haƙuri. A matsayinka na mai mulki, marasa lafiya suna farawa da kashi ɗaya na insulin basal.

Marasa lafiya tare da nau'in ciwon sukari na 1. Thewarin da aka bayar da shawarar farko na Ryzodeg ® FlexTouch the 60-70% ne na yawan insulin yau da kullun a hade tare da insulin gajere / matattara mai ɗaukar nauyi tare da sauran abinci da zaɓi na gaba na yawan ƙwayoyi.

Tsarin allurai mai sauyawa

Lokaci na gudanarwa na miyagun ƙwayoyi Ryzodeg ® FlexTouch ® na iya canzawa idan an canza lokacin babban abincin.

Idan aka rasa kashi na Ryzodeg ® FlexTouch ®, mara lafiya na iya shigar da kashi na gaba a ranar tare da liyafar ta gaba, a rubuta, sannan a koma zuwa lokacin da yake shan magani. Ba za a iya yin ƙarin takaddara don rama wanda aka rasa ba.

Groupsungiyoyin haƙuri na musamman

Tsofaffi marasa lafiya (fiye da 65 shekara). Ana iya amfani da Ryzodeg ® FlexTouch in a cikin tsofaffi marasa lafiya. Yi hankali da lura da tattarawar glucose a cikin jini kuma daidaita sashin insulin daban-daban (duba "Pharmacokinetics").

Marasa lafiya tare da nakasa koda kuma aikin hepatic. Ana iya amfani da Ryzodeg ® FlexTouch in a cikin marasa lafiya da ke fama da rauni game da aiki da kuma hepatic. Yi hankali da lura da tattarawar glucose a cikin jini kuma daidaita sashin insulin daban-daban (duba "Pharmacokinetics").

Yara da matasa. An gabatar da bayanan magungunan data kasance a cikin sashen Pharmacokinetics, duk da haka, inganci da amincin Ryzodeg ® FlexTouch ® a cikin yara da matasa ba suyi nazari ba, kuma ba a ci gaba da shawarar shawarwarin magungunan a cikin yara ba.

Shirye-shiryen Ryzodeg ® FlexTouch ® an yi shi ne kawai don gudanar da sc. Ba za a iya sarrafa magungunan Ryzodeg ® FlexTouch i iv ba. wannan na iya haifar da matsanancin rashin ƙarfi a jiki. Ba za a iya shigar da miyagun ƙwayoyi Ryzodeg ® FlexTouch ® a / m ba, saboda a wannan yanayin, yawan shan magunguna ya canza. Bai kamata ayi amfani da Ryzodeg ® FlexTouch umps a cikin magungunan insulin ba.

Shirye-shiryen Ryzodeg ® FlexTouch is allurar allura ce zuwa cikin cinya, bangon ciki da kuma kafada. Ya kamata a canza wuraren allurar koyaushe a cikin wannan yanki na jiki don rage haɗarin lipodystrophy.

FlexTouch pen syringe pen an tsara shi don amfani dashi tare da allurar diski NovoFayn ® ko NovoTvist ®. FlexTouch ® yana ba ku damar shigar da allurai daga raka'a 1 zuwa 80 a cikin ƙaruwa na 1 naúrar.

Jagorori don amfani da miyagun ƙwayoyi

An riga an gama amfani da alkalami wanda aka riga aka cika Ryzodeg ® FlexTouch ® don amfani da allurar NovoFine ® ko NovoTvist ® har tsawon mm 8 mm. Raizodeg ® FlexTouch ® yana ba ku damar shigar allurai daga raka'a 1 zuwa 80 a cikin ƙaruwa na 1. Bi umarnin dalla-dalla a cikin umarnin haɗe-haɗe don amfani da alkalami FlexTouch ®. Risodeg ® FlexTouch ® da allura sune don amfanin kai kawai.

Kar a cika kwantar da sikirin.

Ba za ku iya amfani da miyagun ƙwayoyi ba idan mafita ta daina zama mara kyau da launi. Ba za ku iya amfani da miyagun ƙwayoyi ba idan an daskarar da shi.

Jefar da allura bayan kowace allura. Ka kiyaye ƙa'idodin gida game da zubar da kayan aikin likita. Bayani dalla-dalla game da yin amfani da alkairin sirinji - duba umarnin marasa lafiya game da amfani da miyagun ƙwayoyi Risedeg ® FlexTouch ®.

Umarnin don marasa lafiya kan yin amfani da maganin Ryzodeg ® FlexTouch for don gudanarwar subcutaneous na 100 PIECES / ml

Dole ne a karanta waɗannan bayanai a hankali kafin amfani da pre-cika FlexTouch ® syringe pen.

Idan mara lafiya bai bi umarnin daidai ba, ana iya ba shi isasshen ko kuma yalwa da yawa na insulin, wanda zai iya haifar da taro mai yawa sosai ko kuma yana ƙasa da glucose na jini. Yi amfani da alkalami kawai bayan mai haƙuri ya koya yin amfani da shi a ƙarƙashin jagorancin likita ko likitan jinya.

Bincika kwalin akan alamar sirinji don tabbatar da cewa ya ƙunshi Ryzodeg ® FlexTouch ®, 100 U / ml, sannan a yi nazarin misalai a ƙasa, wanda ke nuna sassa daban daban na alkairin sirinji da allura.

Idan mara lafiyar yana gani sosai ko yana da wahalar hangen nesa kuma ba zai iya bambance tsakanin lambobin akan takaddar ɗin magani ba, kar a yi amfani da alkalami mai rauni ba tare da taimako ba.

Mai haƙuri na iya taimaka wa mutum ba tare da nakasawar gani ba, a horar da shi daidai yadda ya dace game da abin da aka riga aka cika alkalami na FlexTouch ®.

Ryzodeg ® FlexTouch ® wani alkalami ne wanda aka cika shi wanda ya ƙunshi 300 IU na insulin. Matsakaicin adadin da mai haƙuri zai iya sanyawa shine raka'a 80 a cikin ƙarfe na 1 naúrar. Ryzodeg ® FlexTouch ring syringe alkalami an tsara shi don amfani dashi tare da allurar diski NovoFayn ® ko NovoTvist ® har tsawon mm 8 mm. Ba a haɗa allura cikin kunshin ba.

Bayani mai mahimmanci. Don amintaccen amfani da alkalami, dole ne a saka kulawa ta musamman akan bayanan da aka yiwa alama azaman mahimmanci.

Hoto 4. Ryzodeg ® FlexTouch ® - alkalami mai kaɗa da allura (misali).

I. Shirya alkalami don amfani

A. Duba sunan da sashi akan kwalin sirinji don tabbatar da cewa ya ƙunshi shirye-shiryen Ryzodeg ® FlexTouch,, 100 PIECES / ml. Wannan yana da mahimmanci musamman idan mai haƙuri yayi amfani da nau'ikan shirye-shiryen insulin daban-daban. Idan mara lafiyar yana yin wani nau'in insulin, ƙin karuwar glucose na jini na iya zama ya yi ƙasa sosai ko ya yi ƙasa sosai.

Cire kwalkwali daga alkairin sirinji.

B. Tabbatar da cewa maganin insulin a cikin alkalami bayyananne kuma mara launi. Duba cikin taga girman ma'aunin insulin. Idan maganin insulin yana da gajimare, ba za a iya amfani da alkalami ba.

C. Yi sabon allura da za'a iya cirewa kuma cire sandararren kariya.

D. Saka allura a alkairin sirinji sai a juya shi domin allurar ta huta cikin hular siririn.

E. Cire maɗaurin murfin na ciki, amma kada a zubar dashi. Ana buƙatar bayan an gama allura don a cire allurar lafiya a amince.

F. Cire da zubar da allura ta ciki. Idan mai haƙuri yayi ƙoƙarin mayar da murfin cikin ciki akan allura, yana iya bazarar farat ɗaya. Rabin insulin na iya bayyana a ƙarshen allura. Wannan al'ada ce, duk da haka, har yanzu ya zama dole don bincika isar insulin.

Bayani mai mahimmanci. Yi amfani da sabon allura don kowane allura. Wannan yana rage haɗarin kamuwa da cuta, kamuwa da cuta, yaduwar insulin, toshewar allura da kuma gabatarwar kashi mara kyau na miyagun ƙwayoyi.Karka taɓa amfani da allura idan ya hura ko ya lalace.

Na II. Duba insulin

G. Kafin kowane allura, bincika ɗaukar insulin, don haka mai haƙuri zai iya tabbata cewa ana yin aikin insulin sosai.

Buga raka'a 2 na miyagun ƙwayoyi ta hanyar juya zaɓin mai zaɓin. Tabbatar cewa kwayar ta nuna yana nuna “2”.

H. Yayin riƙe alkalami na syringe tare da allura sama, taɓa sauƙaƙe a saman siririn sirinji sau da yawa tare da yatsanka don iska kuzarin ta tashi.

I. Latsa maɓallin farawa ka riƙe shi a wannan matsayin har sai sirin ɗin ya dawo zuwa sifili. “0” yakamata ya kasance a gaban mai nuna alamar. Wani digo na insulin yakamata ya bayyana a ƙarshen allura.

Blean karamin kumfa na iska na iya kasancewa a ƙarshen allura, amma ba za a allura dashi ba. Idan digo na insulin bai bayyana a ƙarshen allura ba, sake maimaita ayyukan IIG - II I, amma ba fiye da sau 6. Idan digo na insulin bai bayyana ba, canza allura kuma sake maimaita ayyukan IIG - II I. Kada kayi amfani da alkalami idan faɗuwar insulin bai bayyana a ƙarshen allura ba.

Bayani mai mahimmanci. Kafin kowane allura, tabbatar cewa digo na insulin ya bayyana a ƙarshen allura. Wannan yana tabbatar da isar da insulin. Idan digo na insulin bai bayyana ba, ba za a yi amfani da maganin ba, koda kuwa kwayar sikelin ta motsa. Wannan na iya nuna cewa allura ta toshe ko ta lalace. Kafin kowane allura, ya kamata a bincika abincin da ya wuce insulin. Idan mara lafiya bai duba yawan shan insulin din ba, to bazai sami damar sarrafa isasshen yawan insulin din ba ko kuma kwata-kwata, wanda hakan na iya haifar da yawan glucose a cikin jini.

Matsayi na kashi III

J. Kafin fara allurar, tabbatar cewa an saita allurar zuwa “0”. “0” yakamata ya kasance a gaban mai nuna alamar.

Yin amfani da mai zaɓin kashi, daidaita satin kamar yadda likitanka ko ma'aikatan kulawar ka suka ba ka shawarar. Idan an saita kashi mara daidai, zaku iya juya mai zaɓin sashin gaba ko baya har sai an saita madaidaiciyar kashi. Matsakaicin adadin da mai haƙuri zai iya kafawa shine raka'a 80.

Mai zabar kashi yana saita adadin raka'a. Kawai kanannen kashi da alamar nunawa yana nuna adadin raka'a insulin a cikin zaɓin da aka zaɓa. Matsakaicin adadin da za'a iya saita shine raka'a 80. Idan sauran ragowar cikin insulin ɗin cikin sirinji ya ƙaranci raka'a 80, ƙarar ta ƙare za ta tsaya a yawan ɓangaren insulin ɗin da ya rage a firinjin sirinji.

A kowane juzu'in mai zaɓin kashi, ana jin maɓallai, sautin maɓallin ya dogara da wane ɓangaren sashin zaɓin sashi yake juyawa (gaba, baya, ko kuma idan adadin da aka tara ya wuce adadin UNITS na insulin ɗin da ya rage a alƙalin sirinji). Wadannan latsawa bai kamata a kirga su ba.

Bayani mai mahimmanci. Kafin kowane allura, ya kamata ka bincika nawa UNIT na insulin wanda mai haƙuri ya ci a kan ƙwallon da alamun sashi. Kada a ƙidaya danna maɓallin harafin sirinji. Idan aka inganta kuma aka gudanar da shi ba daidai ba, haɗuwar glucose a cikin jini na iya zama ya yi ƙasa sosai ko yayi ƙasa sosai. Matsakaicin ma'aunin insulin yana nuna kimanin adadin insulin da ya saura a alkairin sirinji, don haka ba za'a iya amfani da shi don auna adadin insulin ba.

Gudanar da insulin na IV

K. Sanya allura a karkashin fatarka ta amfani da hanyar allurar da likitan ka ko likitanka suka ba ka. Tabbatar da cewa sashin maganin yana cikin fagen hangen nesa na mai haƙuri. Karka taɓa takaddun kashin tare da yatsunsu - wannan na iya dakatar da allura. Latsa maɓallin farawa gaba ɗaya kuma riƙe shi a wannan matsayin har sai sashin talla ya nuna “0”. "0" dole ne yayi daidai da sigar nuna alama. A wannan yanayin, mai haƙuri na iya ji ko jin dannawa. Bayan allurar, bar allura a karkashin fata na akalla awanni 6. Wannan zai tabbatar da gabatar da cikakken sinadarin insulin.

L. Cire allurar daga karkashin fata ta cire sirinji sama. Idan jini ya bayyana a wurin allurar, a hankali a matse auduga zuwa wurin allurar. Karka tausa wurin allurar.

Bayan an gama allurar, mai haƙuri na iya ganin digo na insulin a ƙarshen allura. Wannan al'ada ce kuma baya tasiri ga adadin maganin da mai haƙuri ya gudanar.

Bayani mai mahimmanci.Koyaushe duba ƙurar kashi don sanin adadin raka'a insulin da mai haƙuri ya gudanar. Kashin maganin zai nuna daidai yawan UNITS. Kada ku kirga yawan dannawa. Riƙe maɓallin farawa har sai takaddar kashi bayan allura ta nuna “0”. Idan kwayar ta rage ya tsaya kafin a nuna “0”, ba a shigar da cikakken insulin na insulin ba, wanda zai iya haifar da yawan glucose a cikin jini.

V. Bayan an gama allurar

M. Tare da filafin allura na waje hutawa a kan shimfiɗaɗɗen ƙasa, saka ƙarshen allura a cikin hula ba tare da taɓa shi ko gefan allura ba.

N. Lokacin da allura ta shiga cikin hula, saka shi a hankali. Cire allurar. Jifa shi da shi a hankali.

A. Bayan kowace allura, ya kamata a saka wata alfarma akan alƙalami don kare insulin da ya ƙunshi daga haɗuwa zuwa haske.

Wajibi ne don fitar da allura bayan kowane allura don guje wa kamuwa da cuta, kamuwa da cuta, yaduwar insulin, toshewar allura da kuma gabatarwar kashi ba daidai ba na maganin. Idan allurar ta toshe, mara lafiya ba zai iya yin allurar insulin ba. A jefa alkalami da aka yi amfani da shi tare da allura mai cire haɗin, daidai da shawarwarin da likitanku, likitan ku, likitan magunguna ko kuma ya dace da buƙatun gida.

Bayani mai mahimmanci. Don hana farashi na bazata, kar a taɓa sake sanya murfin ciki a birin. Cire allurar bayan kowane allura kuma adana allura mai syringe tare da cire allurar. Wannan zai hana kamuwa da cuta, kamuwa da cuta, yaduwar insulin, toshewar allura da kuma gabatarwar kashi mara kyau na miyagun ƙwayoyi.

VI nawa insulin ya rage?

P. Matsayin insulin saura shine yake nuna kimanin adadin insulin da ya saura a alkalami.

R. Don gano nawa insulin ya rage a alƙalami, yi amfani da counter: juya mai zaɓin suturar har sai magungunan ya tsaya. Idan adadin kashi ya nuna lamba 80, wannan yana nuna cewa aƙalla BUDE 80 na insulin ɗin su kasance a aljihun syringe. Idan kwayar magani ta nuna kasa da 80, wannan yana nuna cewa daidai yawan UNITS na insulin da aka nuna akan kwayar kwatancen ya zauna cikin alkairin sirinji. Juya da mai zaɓin sashi a cikin kishiyar sashi har sai sashin ƙaryar ya nuna “0”. Idan sauran insulin ɗin a cikin sirinji na syringe bai isa ba don gudanar da cikakken maganin, zaku iya shigar da adadin da ake buƙata a cikin allura biyu ta amfani da alƙaluman sirinji biyu.

Bayani mai mahimmanci. Dole ne ku yi hankali lokacin yin lissafin ragowar adadin insulin ɗin da ake buƙata. Idan cikin shakka, zai fi kyau gudanar da cikakken insulin ta amfani da sabon alƙalin sirinji. Idan mara lafiya ya yi kuskure a cikin lissafin, zai iya gabatar da isasshen ko kuma yalwar kashi na insulin. Wannan na iya sanya tarowar jini ya yi yawa sosai ko yayi ƙasa sosai.

Bayani mai mahimmanci. Koyaushe ka riƙe alkalami sirinji tare da kai. Koyaushe ɗauka alkalami na ajiyayyu da sabbin allura koda sun ɓace ko sun lalace.

Kiyaye alkalami mai sirinji da allura su isa ga duka, kuma musamman yara. Karka taɓa raba alkairin ka da sauran alluran da shi ga wasu. Wannan na iya haifar da kamuwa da cuta. Karka raba alkalami da wasu. Wannan na iya zama cutarwa ga lafiyarsu.

Yakamata masu kulawa suyi amfani da allurai da aka yi amfani dasu tare da yin taka tsantsan don gujewa allurar bazata da kamuwa da cuta.

Kula da alkalami

Ya kamata a kula da azaman sirinji da kulawa. Kula da rashin kulawa ko kuma rashin kulawa mai kyau na iya haifar da rashin inganci, wanda zai haifar da matsanancin matsayi ko raguwar glucose a cikin jini. Kada ka bar alƙalami a cikin mota ko wani wuri inda zai fallasa shi ga yanayin zafi sosai ko ƙarancin zafi sosai. Kare alkalami cikin ƙura, datti da kowane nau'in taya. Kada ku wanke alkalami, kada ku nutsar da shi cikin ruwa ko sanya shi a ciki. Idan ya cancanta, za'a iya tsabtace alkalami tare da daskararren zane mai laushi tare da sabulu mai laushi.

Kar a jefar ko bugi alƙalami a ƙasa mai tauri. Idan mai haƙuri ya sauke alkalami na syringe ko yana shakkar iyawar sa, to ya zama dole a haɗa sabon allura kuma a duba isowar insulin kafin a yi allura.

Ba a sake sake cika alkairin sirinji ba. Dole ne a zubar da alƙarfan sirinji wofi. Kada ku yi ƙoƙarin gyara sirinji na kanku ko ku ware shi.

Yawan abin sama da ya kamata

Kwayar cutar takamaiman matakin da ya wajaba don samarwar insulin ya wuce, amma hypoglycemia na iya haɓaka a hankali idan kashi na maganin ya yi yawa idan aka kwatanta da buƙata na mai haƙuri (duba "Umarnin na Musamman").

Jiyya: mai haƙuri zai iya kawar da mayuwatsin hankali ta hanyar shan glucose ko samfuran da ke ɗauke da sukari ta bakin. Sabili da haka, an ba da shawarar ga marasa lafiya masu ciwon sukari don ɗaukar samfuran da ke dauke da sukari tare da su. Idan akwai matsalar hypoglycemia mai zafi, lokacin da mara lafiya ya sume, to ya kamata a ba shi glucagon (0.5 zuwa 1 mg IM ko s / c (wanda aka horar zai iya sarrafa shi)), ko kuma maganin IV na dextrose (glucose) (ana iya sarrafa shi kawai Hakanan wajibi ne don gudanar da maganin dextrose iv idan mai haƙuri bai sake dawowa da hankali ba mintina 10-15 bayan aikin glucagon Bayan dawowar halayyar, ana ba da shawarar mai haƙuri ya ɗauki abincin da ke da ƙwayar carbohydrate don hana sake dawowar hauhawar jini.

Umarni na musamman

Hypoglycemia. Cire abinci ko kuma tsananin motsa jiki wanda ba a shirya shi ba na iya haifar da ciwan ƙwanƙwasa jini. Hypoglycemia na iya haɓaka idan kashi na insulin ya yi yawa sosai dangane da bukatun mai haƙuri (duba “Abubuwan sakamako” da “doaukewar cuta”). Bayan ramawa game da metabolism na metabolism (alal misali, tare da ƙwaƙwalwar insulin), marasa lafiya na iya fuskantar alamu na alamu na abubuwan da suka dace na rashin lafiyar hypoglycemia, wanda ya kamata a sanar da marasa lafiya. Alamun gargaɗi na yau da kullun na iya ɓacewa tare da dogon lokaci na ciwon sukari.

Cututtukan da ke haɗuwa, musamman masu kamuwa da cuta tare da zazzabi, yawanci suna ƙaruwa da buƙatar jikin mutum na insulin. Hakanan ana iya buƙatar yin gyaran gyare-gyare idan mai haƙuri yana da koda, hanta, ko ƙyallen hanji, ƙwayar ƙwayar cuta, ko matsalolin thyroid. Kamar yadda sauran shirye-shiryen insal ɗin basal ko shirye-shiryen tare da kayan basal, farfadowa bayan hypoglycemia tare da yin amfani da shirye-shiryen Ryzodeg ® FlexTouch ® na iya yin jinkiri.

Hyperglycemia. Don lura da cututtukan hyperglycemia mai ƙarfi, ana bada shawarar insulin aiki da sauri. Rashin isasshen kashi da / ko dakatarwa da magani a cikin marasa lafiya waɗanda ke buƙatar insulin na iya haifar da haɓakar haɓaka da yiwuwar cutar ketoacidosis mai ciwon sukari. Bugu da ƙari, cututtukan haɗin gwiwa, musamman masu kamuwa da cuta, na iya ba da gudummawa ga ci gaban yanayin hyperglycemic kuma, don haka, haɓaka buƙatun jiki ga insulin. A matsayinka na mulkin, alamun farko na cututtukan hawan jini suna bayyana a hankali, a cikin sa'o'i da yawa ko kwanaki. Wadannan alamomin sun hada da ƙishirwa, saurin fitar iska, tashin zuciya, amai, amai, jan jiki da bushewar fata, bushewar baki, rashin ci, kamshin acetone a cikin iska mai ƙuna. A cikin nau'in 1 na ciwon sukari na mellitus, ba tare da kulawa da ta dace ba, hyperglycemia yana haifar da ci gaban ketoacidosis na ciwon sukari, yanayin da ke da haɗari ga mai mutuwa.

Canja wurin haƙuri daga sauran shirye-shiryen insulin. Canza haƙuri ga sabon nau'in ko shiri na insulin na sabon alama ko wani mai samarwa dole ne ya faru a ƙarƙashin kulawar likita. Lokacin yin fassarar, ana iya buƙatar daidaita sashi.

Yin amfani da kwayoyi na lokaci guda na ƙungiyar thiazolidinedione da shirye-shiryen insulin. An ba da rahoton lambobin ci gaban CHF a cikin lura da marasa lafiya da thiazolidinediones a hade tare da shirye-shiryen insulin, musamman idan irin waɗannan marasa lafiya suna da abubuwan haɗari don haɓakar bugun zuciya na kullum. Ya kamata a yi la'akari da wannan gaskiyar yayin rubuta magunguna masu haɗuwa tare da thiazolidinediones da magungunan Ryzodeg ® FlexTouch ® ga marasa lafiya.

Lokacin da ake rubuta irin wannan haɗin haɗin gwiwa, ya zama dole a gudanar da gwaje-gwajen likita na marasa lafiya don gano alamun da alamun rashin lafiyar zuciya, yawan nauyi da kuma kasancewar ƙwayar cuta na gefe. Idan alamun cututtukan zuciya sun lalace a cikin marasa lafiya, tilas a dakatar da jiyya tare da thiazolidinediones.

Vioarya ta sashin hangen nesa. Intensation na insulin farjin tare da ingantacciyar ci gaba a cikin sarrafa metabolism na metabolism na iya haifar da lalacewa ta ɗan lokaci a cikin yanayin maganin ciwon sukari, yayin da ci gaba na dogon lokaci a cikin kulawar glycemic yana rage haɗarin ci gaban cututtukan ciwon sukari.

Yin rigakafin rikice rikice na shirye-shiryen insulin. Yakamata a umurci mara lafiya ya duba alamar a kan kowane alama kafin kowane allura don kauce wa rikicewar haɗari na shirye-shiryen Ryzodeg ® FlexTouch with tare da sauran shirye-shiryen insulin.

Marasa lafiya yakamata a duba sigar a kan allurar ta allurar. Don haka, kawai marasa lafiya waɗanda zasu iya bambanta lambobin a kan adadin sirinji na sirinji na iya ba da izinin insulin akan nasu.

Wajibi ne a sanar da marasa lafiya makafi ko mutanen da ke da rauni na gani cewa koyaushe suna buƙatar taimakon mutanen da ba su da wahalar hangen nesa kuma an horar da su don yin aiki tare da injector.

Kwayoyin rigakafi zuwa insulin. Lokacin amfani da insulin, ɗayan rigakafin yana yiwuwa. A cikin mafi yawan lokuta, ƙirƙirar rigakafin ƙwayar cuta na iya buƙatar daidaita sashi na insulin don hana lokuta na hyperglycemia ko hypoglycemia.

Tasiri kan iya tuka motoci da abubuwan aiki. Thearfin marasa lafiya su mai da hankali kuma ana iya rage ƙarancin amsawar a lokacin rashin ƙarfi, wanda zai iya zama haɗari a cikin yanayi inda wannan damar ta zama dole musamman (alal misali, lokacin tuki motoci ko aiki tare da injin).

Ya kamata a shawarci marassa lafiya su dauki matakan hana ci gaban hauhawar jini yayin tuki. Wannan yana da mahimmanci musamman ga marasa lafiya da basu da cikakkun alamu na abubuwan ci gaban haila ko tare da rikicewar yanayin yawan haila. A waɗannan halayen, yakamata ayi la'akari da dacewar tuki.